Skip to main content
Top
Published in: BMC Nephrology 1/2019

Open Access 01-12-2019 | Arteriovenous Fistula | Research article

Impact of Arteriovenous fistula creation on estimated glomerular filtration rate decline in Predialysis patients

Authors: Valérie Bénard, Maude Pichette, Jean-Philippe Lafrance, Naoual Elftouh, Vincent Pichette, Louis-Philippe Laurin, Annie-Claire Nadeau-Fredette

Published in: BMC Nephrology | Issue 1/2019

Login to get access

Abstract

Background

Arteriovenous fistula (AVF) is the vascular access of choice for patients on hemodialysis. Recent evidence suggests that AVF creation may slow estimated glomerular filtration rate (eGFR) decline. The study objective was to assess the impact of the AVF creation on eGFR decline, after controlling for key confounding factors.

Methods

This retrospective cohort study included adult patients followed in a single-center predialysis clinic between 1999 and 2016. Patients with a patent AVF were followed up to 2 years pre- and post-AVF creation. Estimated GFR trajectory was reported using linear mixed models adjusted for demographic characteristics, comorbidities and use of renin-angiotensin-aldosterone blockade.

Results

A total of 146 patients were studied with a median age 68.7 (60.5–75.4) years and a median eGFR at time of AVF creation of 12.8 (11.3–13.9) mL/min/1.73m2. The crude annual eGFR decline rates were − 3.60 ± 4.00 mL/min/1.73 m2 pre- and − 2.28 ± 3.56 mL/min/1.73 m2 post-AVF, resulting in a mean difference of 1.28 mL/min/1.73 m2 (95% CI 0.49, 2.07). In a mixed effect linear regression model, monthly eGFR decline was − 0.63 (95% CI -0.81, − 0.46; p <  0.001) mL/min/1.73m2/month. The period after AVF creation was associated with a relatively higher eGFR (β 0.94, 95% CI 0.61–1.26, p <  0.001). There was a significant association between follow-up time and the period pre/post AVF (β 0.19, 95% CI 0.16, 0.22; p <  0.001) such that eGFR decline was more attenuated each month after AVF creation.

Conclusions

In this cohort, AVF creation was associated with a significant reduction of eGFR decline. Further prospective studies are needed to confirm this association.
Appendix
Available only for authorised users
Literature
1.
go back to reference National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39(2 Suppl 1):S1–266. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39(2 Suppl 1):S1–266.
2.
go back to reference United States Renal Data System USRDS. 2016 annual data report: epidemiology of kidney disease in the United States. MD: Bethesda; 2016. United States Renal Data System USRDS. 2016 annual data report: epidemiology of kidney disease in the United States. MD: Bethesda; 2016.
4.
go back to reference United States Renal Data System USRDS. 2013 annual data report: atlas of chronic kidney disease and end-stage renal disease in the United States. Bethesda, MD 2013. United States Renal Data System USRDS. 2013 annual data report: atlas of chronic kidney disease and end-stage renal disease in the United States. Bethesda, MD 2013.
5.
go back to reference De Vecchi AF, Dratwa M, Wiedemann ME. Healthcare systems and end-stage renal disease (ESRD) therapies--an international review: costs and reimbursement/funding of ESRD therapies. Nephrol Dial Transplant. 1999;14(Suppl 6):31–41.CrossRef De Vecchi AF, Dratwa M, Wiedemann ME. Healthcare systems and end-stage renal disease (ESRD) therapies--an international review: costs and reimbursement/funding of ESRD therapies. Nephrol Dial Transplant. 1999;14(Suppl 6):31–41.CrossRef
6.
go back to reference Himmelfarb J. Hemodialysis complications. Am J Kidney Dis. 2005;45(6):1122–31.CrossRef Himmelfarb J. Hemodialysis complications. Am J Kidney Dis. 2005;45(6):1122–31.CrossRef
7.
go back to reference AlDukhayel A. Prevalence of depressive symptoms among hemodialysis and peritoneal Dialysis patients. Int J Health Sci. 2015;9(1):9–16.CrossRef AlDukhayel A. Prevalence of depressive symptoms among hemodialysis and peritoneal Dialysis patients. Int J Health Sci. 2015;9(1):9–16.CrossRef
8.
go back to reference Nassar GM, Ayus JC. Infectious complications of the hemodialysis access. Kidney Int. 2001;60(1):1–13.CrossRef Nassar GM, Ayus JC. Infectious complications of the hemodialysis access. Kidney Int. 2001;60(1):1–13.CrossRef
9.
go back to reference Gerogianni S, Babatsikou F, Gerogianni G, Koutis C, Panagiotou M, Psimenou E. Social life of patients undergoing haemodialysis International Journal of Caring Sciences 2016;9(1):122–34. Gerogianni S, Babatsikou F, Gerogianni G, Koutis C, Panagiotou M, Psimenou E. Social life of patients undergoing haemodialysis International Journal of Caring Sciences 2016;9(1):122–34.
10.
go back to reference Golper TA, Hartle PM, Bian A. Arteriovenous fistula creation may slow estimated glomerular filtration rate trajectory. Nephrol Dial Transplant. 2015;30(12):2014–8.CrossRef Golper TA, Hartle PM, Bian A. Arteriovenous fistula creation may slow estimated glomerular filtration rate trajectory. Nephrol Dial Transplant. 2015;30(12):2014–8.CrossRef
11.
go back to reference Sumida K, Molnar MZ, Potukuchi PK, Thomas F, Lu JL, Ravel VA, et al. Association between vascular access creation and deceleration of estimated glomerular filtration rate decline in late-stage chronic kidney disease patients transitioning to end-stage renal disease. Nephrol Dial Transplant 2016;0:1–8. Sumida K, Molnar MZ, Potukuchi PK, Thomas F, Lu JL, Ravel VA, et al. Association between vascular access creation and deceleration of estimated glomerular filtration rate decline in late-stage chronic kidney disease patients transitioning to end-stage renal disease. Nephrol Dial Transplant 2016;0:1–8.
12.
go back to reference Inker LA, Astor BC, Fox CH, Isakova T, Lash JP, Peralta CA, et al. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD. Am J Kidney Dis. 2014;63(5):713–35.CrossRef Inker LA, Astor BC, Fox CH, Isakova T, Lash JP, Peralta CA, et al. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD. Am J Kidney Dis. 2014;63(5):713–35.CrossRef
13.
go back to reference Ravani P, Palmer SC, Oliver MJ, Quinn RR, MacRae JM, Tai DJ, et al. Associations between hemodialysis access type and clinical outcomes: a systematic review. J Am Soc Nephrol. 2013;24(3):465–73.CrossRef Ravani P, Palmer SC, Oliver MJ, Quinn RR, MacRae JM, Tai DJ, et al. Associations between hemodialysis access type and clinical outcomes: a systematic review. J Am Soc Nephrol. 2013;24(3):465–73.CrossRef
14.
go back to reference Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–12.CrossRef Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–12.CrossRef
15.
go back to reference Leffondre K, Boucquemont J, Tripepi G, Stel VS, Heinze G, Dunkler D. Analysis of risk factors associated with renal function trajectory over time: a comparison of different statistical approaches. Nephrol Dial Transplant. 2015;30(8):1237–43.CrossRef Leffondre K, Boucquemont J, Tripepi G, Stel VS, Heinze G, Dunkler D. Analysis of risk factors associated with renal function trajectory over time: a comparison of different statistical approaches. Nephrol Dial Transplant. 2015;30(8):1237–43.CrossRef
16.
go back to reference Weekers L, Vanderweckene P, Pottel H, Castanares-Zapatero D, Bonvoisin C, Hamoir E, et al. The closure of arteriovenous fistula in kidney transplant recipients is associated with an acceleration of kidney function decline. Nephrol Dial Transplant. 2017;32(1):196–200.PubMed Weekers L, Vanderweckene P, Pottel H, Castanares-Zapatero D, Bonvoisin C, Hamoir E, et al. The closure of arteriovenous fistula in kidney transplant recipients is associated with an acceleration of kidney function decline. Nephrol Dial Transplant. 2017;32(1):196–200.PubMed
17.
go back to reference Levin A, Djurdjev O, Beaulieu M, Er L. Variability and risk factors for kidney disease progression and death following attainment of stage 4 CKD in a referred cohort. Am J Kidney Dis. 2008;52(4):661–71.CrossRef Levin A, Djurdjev O, Beaulieu M, Er L. Variability and risk factors for kidney disease progression and death following attainment of stage 4 CKD in a referred cohort. Am J Kidney Dis. 2008;52(4):661–71.CrossRef
18.
go back to reference Al-Balas A, Lee T, Young CJ, Barker-Finkel J, Allon M. Predictors of initiation for Predialysis Arteriovenous fistula. Clin J Am Soc Nephrol. 2016;11(10):1802–8.CrossRef Al-Balas A, Lee T, Young CJ, Barker-Finkel J, Allon M. Predictors of initiation for Predialysis Arteriovenous fistula. Clin J Am Soc Nephrol. 2016;11(10):1802–8.CrossRef
19.
go back to reference Liu Z, Gong R. Remote ischemic preconditioning for kidney protection: GSK3β-centric insights into the mechanism of action. Am J Kidney Dis. 2015;66(5):846–56.CrossRef Liu Z, Gong R. Remote ischemic preconditioning for kidney protection: GSK3β-centric insights into the mechanism of action. Am J Kidney Dis. 2015;66(5):846–56.CrossRef
20.
go back to reference Endre ZH. Renal ischemic preconditioning: finally some good news for prevention of acute kidney injury. Kidney Int. 2011;80(8):796–8.CrossRef Endre ZH. Renal ischemic preconditioning: finally some good news for prevention of acute kidney injury. Kidney Int. 2011;80(8):796–8.CrossRef
21.
go back to reference Er F, Nia AM, Dopp H, Hellmich M, Dahlem KM, Caglayan E, et al. Ischemic preconditioning for prevention of contrast medium-induced nephropathy: randomized pilot RenPro trial (renal protection trial). Circulation. 2012;126(3):296–303.CrossRef Er F, Nia AM, Dopp H, Hellmich M, Dahlem KM, Caglayan E, et al. Ischemic preconditioning for prevention of contrast medium-induced nephropathy: randomized pilot RenPro trial (renal protection trial). Circulation. 2012;126(3):296–303.CrossRef
22.
go back to reference Gassanov N, Nia AM, Caglayan E, Er F. Remote ischemic preconditioning and renoprotection: from myth to a novel therapeutic option? J Am Soc Nephrol. 2014;25(2):216–24.CrossRef Gassanov N, Nia AM, Caglayan E, Er F. Remote ischemic preconditioning and renoprotection: from myth to a novel therapeutic option? J Am Soc Nephrol. 2014;25(2):216–24.CrossRef
23.
go back to reference Stolic RV, Trajkovic GZ, Miric DJ, Kisic B, Djordjevic Z, Azanjac GL, et al. Arteriovenous fistulas and digital hypoperfusion ischemic syndrome in patients on hemodialysis. World J Nephrology. 2013;2(2):26–30.CrossRef Stolic RV, Trajkovic GZ, Miric DJ, Kisic B, Djordjevic Z, Azanjac GL, et al. Arteriovenous fistulas and digital hypoperfusion ischemic syndrome in patients on hemodialysis. World J Nephrology. 2013;2(2):26–30.CrossRef
24.
go back to reference Basile C, Lomonte C, Vernaglione L, Casucci F, Antonelli M, Losurdo N. The relationship between the flow of arteriovenous fistula and cardiac output in haemodialysis patients. Nephrol Dial Transplant. 2008;23(1):282–7.CrossRef Basile C, Lomonte C, Vernaglione L, Casucci F, Antonelli M, Losurdo N. The relationship between the flow of arteriovenous fistula and cardiac output in haemodialysis patients. Nephrol Dial Transplant. 2008;23(1):282–7.CrossRef
25.
go back to reference Korsheed S, Eldehni MT, John SG, Fluck RJ, McIntyre CW. Effects of arteriovenous fistula formation on arterial stiffness and cardiovascular performance and function. Nephrol Dial Transplant. 2011;26(10):3296–302.CrossRef Korsheed S, Eldehni MT, John SG, Fluck RJ, McIntyre CW. Effects of arteriovenous fistula formation on arterial stiffness and cardiovascular performance and function. Nephrol Dial Transplant. 2011;26(10):3296–302.CrossRef
26.
go back to reference Gosse P, Safar ME. Arterial stiffness and plasma Creatinine in untreated hypertensive patients. Am J Hypertens. 2005;18(9):1140–5.CrossRef Gosse P, Safar ME. Arterial stiffness and plasma Creatinine in untreated hypertensive patients. Am J Hypertens. 2005;18(9):1140–5.CrossRef
27.
go back to reference Wang MC, Tsai WC, Chen JY, Huang JJ. Stepwise increase in arterial stiffness corresponding with the stages of chronic kidney disease. Am J Kidney Dis. 2005;45(3):494–501.CrossRef Wang MC, Tsai WC, Chen JY, Huang JJ. Stepwise increase in arterial stiffness corresponding with the stages of chronic kidney disease. Am J Kidney Dis. 2005;45(3):494–501.CrossRef
28.
go back to reference Mathew RO, Fleg J, Rangaswami J, Cai B, Asif A, Sidhu MS, et al. Effect of Arteriovenous fistula creation on systolic and diastolic blood pressure in patients with pre-dialysis advanced chronic kidney disease. Am J Hypertens. 2019;32(9):858–67.CrossRef Mathew RO, Fleg J, Rangaswami J, Cai B, Asif A, Sidhu MS, et al. Effect of Arteriovenous fistula creation on systolic and diastolic blood pressure in patients with pre-dialysis advanced chronic kidney disease. Am J Hypertens. 2019;32(9):858–67.CrossRef
29.
go back to reference Lynch SK, Ahanchi SS, Dexter DJ, Glickman MH, Panneton JM. Patient compliance limits the efforts of quality improvement initiatives on arteriovenous fistula maturation. J Vasc Surg. 2015;61(1):184–91.CrossRef Lynch SK, Ahanchi SS, Dexter DJ, Glickman MH, Panneton JM. Patient compliance limits the efforts of quality improvement initiatives on arteriovenous fistula maturation. J Vasc Surg. 2015;61(1):184–91.CrossRef
30.
go back to reference O'Hare AM, Batten A, Burrows NR, Pavkov ME, Taylor L, Gupta I, et al. Trajectories of kidney function decline in the 2 years before initiation of long-term dialysis. Am J Kidney Dis. 2012;59(4):513–22.CrossRef O'Hare AM, Batten A, Burrows NR, Pavkov ME, Taylor L, Gupta I, et al. Trajectories of kidney function decline in the 2 years before initiation of long-term dialysis. Am J Kidney Dis. 2012;59(4):513–22.CrossRef
31.
go back to reference Evans M, Tettamanti G, Nyren O, Bellocco R, Fored CM, Elinder CG. No survival benefit from early-start dialysis in a population-based, inception cohort study of Swedish patients with chronic kidney disease. J Intern Med. 2011;269(3):289–98.CrossRef Evans M, Tettamanti G, Nyren O, Bellocco R, Fored CM, Elinder CG. No survival benefit from early-start dialysis in a population-based, inception cohort study of Swedish patients with chronic kidney disease. J Intern Med. 2011;269(3):289–98.CrossRef
32.
go back to reference Pisoni RL, Zepel L, Port FK, Robinson BM. Trends in US vascular access use, patient preferences, and related practices: an update from the US DOPPS practice monitor with international comparisons. Am J Kidney Dis. 2015;65(6):905–15.CrossRef Pisoni RL, Zepel L, Port FK, Robinson BM. Trends in US vascular access use, patient preferences, and related practices: an update from the US DOPPS practice monitor with international comparisons. Am J Kidney Dis. 2015;65(6):905–15.CrossRef
33.
go back to reference Shechter SM, Skandari MR, Zalunardo N. Timing of arteriovenous fistula creation in patients with CKD: a decision analysis. Am J Kidney Dis. 2014;63(1):95–103.CrossRef Shechter SM, Skandari MR, Zalunardo N. Timing of arteriovenous fistula creation in patients with CKD: a decision analysis. Am J Kidney Dis. 2014;63(1):95–103.CrossRef
34.
go back to reference Di Lullo L, Bellasi A, Barbera V, Russo D, Russo L, Di Iorio B, et al. Pathophysiology of the cardio-renal syndromes types 1-5: an uptodate. Indian Heart J. 2017;69(2):255–65.CrossRef Di Lullo L, Bellasi A, Barbera V, Russo D, Russo L, Di Iorio B, et al. Pathophysiology of the cardio-renal syndromes types 1-5: an uptodate. Indian Heart J. 2017;69(2):255–65.CrossRef
35.
go back to reference National Kidney Foundation. Clinical practice guidelines for vascular access. Clinical Practice Guideline 2: Selection and placement of hemodialysis access. Am J Kidney Dis. 2008;48(Suppl 1):S248–73. National Kidney Foundation. Clinical practice guidelines for vascular access. Clinical Practice Guideline 2: Selection and placement of hemodialysis access. Am J Kidney Dis. 2008;48(Suppl 1):S248–73.
36.
go back to reference Ferro CJ, Savage T, Pinder SJ, Tomson CR. Central aortic pressure augmentation in stable renal transplant recipients. Kidney Int. 2002;62(1):166–71.CrossRef Ferro CJ, Savage T, Pinder SJ, Tomson CR. Central aortic pressure augmentation in stable renal transplant recipients. Kidney Int. 2002;62(1):166–71.CrossRef
37.
go back to reference Keuter XH, Kooman JP, Habets J, Van Der Sande FM, Kessels AG, Cheriex EC, et al. Effect of upper arm brachial basilic and prosthetic forearm arteriovenous fistula on left ventricular hypertrophy. J Vasc Access. 2007;8(4):296–301.CrossRef Keuter XH, Kooman JP, Habets J, Van Der Sande FM, Kessels AG, Cheriex EC, et al. Effect of upper arm brachial basilic and prosthetic forearm arteriovenous fistula on left ventricular hypertrophy. J Vasc Access. 2007;8(4):296–301.CrossRef
38.
go back to reference Stern AB, Klemmer PJ. High-output heart failure secondary to arteriovenous fistula. Hemodial Int. 2011;15(1):104–7.CrossRef Stern AB, Klemmer PJ. High-output heart failure secondary to arteriovenous fistula. Hemodial Int. 2011;15(1):104–7.CrossRef
39.
go back to reference MacRae JM, Pandeya S, Humen DP, Krivitski N, Lindsay RM. Arteriovenous fistula-associated high-output cardiac failure: a review of mechanisms. Am J Kidney Dis. 2004;43(5):e17–22.CrossRef MacRae JM, Pandeya S, Humen DP, Krivitski N, Lindsay RM. Arteriovenous fistula-associated high-output cardiac failure: a review of mechanisms. Am J Kidney Dis. 2004;43(5):e17–22.CrossRef
40.
go back to reference Yigla M, Abassi Z, Reisner SA, Nakhoul F. Pulmonary hypertension in hemodialysis patients: an unrecognized threat. Semin Dial. 2006;19(5):353–7.CrossRef Yigla M, Abassi Z, Reisner SA, Nakhoul F. Pulmonary hypertension in hemodialysis patients: an unrecognized threat. Semin Dial. 2006;19(5):353–7.CrossRef
Metadata
Title
Impact of Arteriovenous fistula creation on estimated glomerular filtration rate decline in Predialysis patients
Authors
Valérie Bénard
Maude Pichette
Jean-Philippe Lafrance
Naoual Elftouh
Vincent Pichette
Louis-Philippe Laurin
Annie-Claire Nadeau-Fredette
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2019
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-019-1607-4

Other articles of this Issue 1/2019

BMC Nephrology 1/2019 Go to the issue